Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jan 31, 2025 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expense | 25.58%45.09K | 416.92%34.98K | 35.9K | 9.55K | 18.08K | 6.77K |
| Selling and administrative expenses | -5.35%33.96K | 378.74%29.97K | --35.88K | --9.55K | --18.58K | --6.26K |
| -General and administrative expense | -5.35%33.96K | 378.74%29.97K | --35.88K | --9.55K | --18.58K | --6.26K |
| Other operating expenses | 52,876.19%11.13K | 890.30%5K | --21 | ---- | ---- | --505 |
| Operating profit | -25.58%-45.09K | -416.92%-34.98K | -35.9K | -9.55K | -18.08K | -6.77K |
| Net non-operating interest income (expenses) | -126.74%-77.41K | -129.09%-42.95K | -34.14K | -28.4K | -27.51K | -18.75K |
| Non-operating interest income | 265.88%7.15K | --3.47K | --1.96K | --2.17K | --1.7K | --0 |
| Non-operating interest expense | 134.27%84.56K | 147.57%46.42K | --36.1K | --30.57K | --29.21K | --18.75K |
| Other net income (expenses) | ||||||
| Income before tax | -74.89%-122.5K | -205.42%-77.92K | -70.04K | -37.95K | -45.59K | -25.51K |
| Income tax | ||||||
| Earnings from equity interest net of tax | ||||||
| Net income | -74.89%-122.5K | -205.42%-77.92K | -70.04K | -37.95K | -45.59K | -25.51K |
| Net income continuous operations | -74.89%-122.5K | -205.42%-77.92K | ---70.04K | ---37.95K | ---45.59K | ---25.51K |
| Noncontrolling interests | ||||||
| Net income attributable to the company | -74.89%-122.5K | -205.42%-77.92K | -70.04K | -37.95K | -45.59K | -25.51K |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | -74.89%-122.5K | -205.42%-77.92K | -70.04K | -37.95K | -45.59K | -25.51K |
| Diluted earnings per share | -57.75%-0.01 | -205.41%-0.0071 | -0.0063 | -0.0034 | -0.0041 | -0.0023 |
| Basic earnings per share | -57.75%-0.01 | -205.41%-0.0071 | -0.0063 | -0.0034 | -0.0041 | -0.0023 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.